ATOSSA THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 11336710, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2019-01-01 – 2019-09-30
Statuscurrent
EntityATOSSA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001437749-19-022613 · Open the official SEC filing →
Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001488039/cashflow-financing/2019-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/36508904-ee3f-4da7-9707-cd9b9990e2e1

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies